Clinical Trials Directory

Trials / Completed

CompletedNCT01868165

Assessing the Impact of Calcium Channel Blockers on COGnitive Function in the Very Elderly (AI-COG)

Status
Completed
Phase
Study type
Observational
Enrollment
337 (actual)
Sponsor
Imperial College London · Academic / Other
Sex
All
Age
80 Years
Healthy volunteers
Not accepted

Summary

Older adults are at increased risk of high blood pressure and cognitive decline. High blood pressure itself also increases risk of cognitive decline. A particular type of blood pressure lowering drug (a calcium channel blocker(CCB)) may lower risk of dementia in younger adults but there is no clear evidence of it's impact in those \>=80. It is important that we know whether CCB use impacts on cognitive function in this age group. This study will examine the impact of antihypertensives on change in cognitive function with a particular focus on CCBs.

Detailed description

This study is an observational cohort study examining cognitive change in those participants taking antihypertensives and aged 80 and over and examining cognitive change in participants taking different types of antihypertensive medication.

Conditions

Timeline

Start date
2013-06-01
Primary completion
2015-02-01
Completion
2016-02-01
First posted
2013-06-04
Last updated
2019-09-23
Results posted
2019-09-23

Locations

7 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01868165. Inclusion in this directory is not an endorsement.